1Arang PC,Raskin P.Hypertention in diabetes menintus.Endocrinol Metab Clin North Am,1996,5:401
2UK Prospective Diabetes Study Group,Tigyt blood pressure control and risk of macrovascular and microvasoalar complications in type 2 diabetes:UKPDS 38.Br Med,1998,317:703.
4Macmahon S,Peto R,Culter J,et al.Blood pressure,storke and coranary heatr disease.Lancet,1990,335:765.
二级参考文献6
1Reaven GM, et al. Mechanism of disease: Hypertension and associated metabolic abnormalities The role of insulin resistance and the sympathoadnenal system. N Engl J Med 1996;334(6):374.
2Moogennsen CE, Editorals: Combined high blood pressure and glucose in type 2 diabetes:double jeopardy BMJ 1998;317:693.
3UKPDS Group. Tight blood pressure contol and risk of macrolascular and rnicrovascular complications in type 2 diabetes.UKPDS 38, BMJ 1998;317:703.
4UKPDS Group Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39. BMJ 1998;317:713.
5Nathan DM, Commentary: Some answers, more controversy, form UKPDS. THe Lancet 1998 ;352: 832.
6ADA. Position statement: Implications of the United Kingdom prospective Diabetes Study. Diabetes Care 1999;22(Suppl.1):S27.
